Genomics Biotech Ltd - Stock Valuation and Financial Performance

BSE: 524011 | NSE: | Consumer Food | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Genomics Biotech

M-Cap below 100cr DeciZen not available

Genomics Biotech stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
2.6 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Genomics Biotech :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13TTM
ROCE % 0%0%0%0%0%0%0%-0.1%-0%-0%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000000000
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS 0000000-0000
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 000000010.910.910.910
Adj Net
Profit
00000000000
Cash Flow from Ops. 0000000000.1-
Debt/CF from Ops. 0000000154.8-345.911-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPSNANANA0%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13TTM
Return on
Equity %
0000000-0.1-0-00
Op. Profit
Mgn %
00000000006.3
Net Profit
Mgn %
0000000000NAN
Debt to
Equity
00000000.10.10.1-
Working Cap
Days
00000000000
Cash Conv.
Cycle
00000000000

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Genomics Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 10 -
Reserves (₹ Cr.) - -
P/BV 0.14 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 0.90 / 19.95
Market Cap (₹ Cr.) 2.6
Equity (₹ Cr.) 18.2
Face Value (₹) 10
Industry PE 66.1

Management X-Ray of Genomics Biotech :

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Genomics Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13
Sales000
Operating Expenses 000
Manufacturing Costs000
Material Costs000
Employee Cost 000
Other Costs 000
Operating Profit 000
Operating Profit Margin (%) ---
Other Income 000
Interest 000
Depreciation 0.0100
Exceptional Items 000
Profit Before Tax -0.0100
Tax 000
Profit After Tax -0.0100
PAT Margin (%) ---
Adjusted EPS (₹)0.00.00.0
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13

Equity and Liabilities

Shareholders Fund 21.2221.2221.22
Share Capital 18.1818.1818.18
Reserves 3.043.043.04
Minority Interest000
Debt1.371.371.37
Long Term Debt1.371.371.37
Short Term Debt000
Trade Payables000
Others Liabilities 0.860.850.85
Total Liabilities 23.4423.4423.44

Fixed Assets

Gross Block0.090.090.09
Accumulated Depreciation0.090.090.09
Net Fixed Assets000
CWIP 000
Investments 101010
Inventories000
Trade Receivables0.130.130
Cash Equivalents 0.090.090.22
Others Assets13.2213.2213.22
Total Assets 23.4423.4423.44

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13
Cash Flow From Operating Activity 0.0100.12
PBT -0.0100
Adjustment 0.0100
Changes in Working Capital 0.01-00.13
Tax Paid 000
Cash Flow From Investing Activity 000
Capex 000
Net Investments 000
Others 000
Cash Flow From Financing Activity 000
Net Proceeds from Shares 000
Net Proceeds from Borrowing 000
Interest Paid 000
Dividend Paid 000
Others 000
Net Cash Flow 0.0100.12
PARTICULARSMar'11Mar'12Mar'13
Ratios
ROE (%)-0.05-0.01-0.01
ROCE (%)-0.05-0.01-0.01
Asset Turnover Ratio000
PAT to CFO Conversion(x)N/AN/AN/A
Working Capital Days
Receivable Days000
Inventory Days000
Payable Days000

Genomics Biotech Ltd Stock News

Genomics Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Genomics Biotech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Genomics Biotech stood at ₹2.58.
The latest P/E ratio of Genomics Biotech as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Genomics Biotech as of 01-Jan-1970 05:30 is 0.14.
The 52-week high of Genomics Biotech is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Genomics Biotech is ₹0.00 ( Cr.) .

About Genomics Biotech Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.